Sanjay Subramanian - 29 Sep 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay S. Subramanian
Issuer symbol
INZY
Transactions as of
29 Sep 2023
Net transactions value
+$8,279
Form type
4
Filing time
03 Oct 2023, 16:05:26 UTC
Previous filing
04 Apr 2023
Next filing
15 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $8,279 +2,319 +8.3% $3.57 30,398 29 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2023 through September 30, 2023. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on September 29, 2023, the last trading day of the purchase period.